Heather Cahan

617 total citations · 1 hit paper
16 papers, 418 citations indexed

About

Heather Cahan is a scholar working on Physiology, Rheumatology and Cell Biology. According to data from OpenAlex, Heather Cahan has authored 16 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Physiology, 6 papers in Rheumatology and 4 papers in Cell Biology. Recurrent topics in Heather Cahan's work include Lysosomal Storage Disorders Research (11 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Cellular transport and secretion (4 papers). Heather Cahan is often cited by papers focused on Lysosomal Storage Disorders Research (11 papers), Glycogen Storage Diseases and Myoclonus (6 papers) and Cellular transport and secretion (4 papers). Heather Cahan collaborates with scholars based in United States, Germany and United Kingdom. Heather Cahan's co-authors include Temitayo Ajayi, Peter Slasor, Nicola Specchio, Emily de los Reyes, Paul Gissen, Angela Schulz, David Jacoby, Jonathan P. Dyke, Alfried Kohlschütter and Douglas Ballon and has published in prestigious journals such as New England Journal of Medicine, International Journal of Molecular Sciences and Clinical Immunology.

In The Last Decade

Heather Cahan

16 papers receiving 412 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Study of Intraventricular Cerliponase Alfa for CLN2 Disease

2018 310 citations Angela Schulz, Temitayo Ajayi et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Heather Cahan United States	7	265	119	115	76	71	16	418
Miriam Nickel Germany	12	257 1.0×	119 1.0×	109 0.9×	40 0.5×	99 1.4×	38	385
Patrick A. Lundquist United States	8	238 0.9×	130 1.1×	46 0.4×	55 0.7×	40 0.6×	16	440
Mahesh Kamate India	11	149 0.6×	142 1.2×	66 0.6×	39 0.5×	38 0.5×	59	426
Eugênia Ribeiro Valadares Brazil	12	159 0.6×	149 1.3×	45 0.4×	148 1.9×	90 1.3×	38	433
Norberto Guelbert Argentina	16	514 1.9×	148 1.2×	105 0.9×	58 0.8×	232 3.3×	39	651
Therese Ruane United States	7	294 1.1×	176 1.5×	78 0.7×	178 2.3×	35 0.5×	11	510
Xinying Hong United States	12	303 1.1×	136 1.1×	53 0.5×	38 0.5×	35 0.5×	41	441
Christine Broissand France	7	175 0.7×	138 1.2×	51 0.4×	130 1.7×	66 0.9×	10	416
Alessandra Zanetti Italy	13	337 1.3×	109 0.9×	87 0.8×	50 0.7×	89 1.3×	22	419
Hadhami Ben Turkia Tunisia	13	417 1.6×	171 1.4×	153 1.3×	39 0.5×	53 0.7×	46	524

Countries citing papers authored by Heather Cahan

Since Specialization

Citations

This map shows the geographic impact of Heather Cahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heather Cahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heather Cahan more than expected).

Fields of papers citing papers by Heather Cahan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heather Cahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heather Cahan. The network helps show where Heather Cahan may publish in the future.

Co-authorship network of co-authors of Heather Cahan

This figure shows the co-authorship network connecting the top 25 collaborators of Heather Cahan. A scholar is included among the top collaborators of Heather Cahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heather Cahan. Heather Cahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Schulz, Angela, Emily de los Reyes, Nicola Specchio, et al.. (2020). Cerliponase alfa for the treatment of CLN2 disease in an expanded patient cohort including children younger than three years: Interim results from an ongoing clinical study. Molecular Genetics and Metabolism. 129(2). S145–S145. 1 indexed citations

Bhalla, Akhil, Ritesh Ravi, Meng Fang, et al.. (2020). Characterization of Fluid Biomarkers Reveals Lysosome Dysfunction and Neurodegeneration in Neuronopathic MPS II Patients. International Journal of Molecular Sciences. 21(15). 5188–5188. 21 indexed citations

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2019). Persistent Treatment Effect of Cerliponase Alfa in Children with CLN2 Disease: A 3 Year Update from an Ongoing Multicenter Extension Study. Neuropediatrics. 6 indexed citations

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2019). Persistent treatment effect of cerliponase alfa in children with CLN2 disease: A 3 year update from an ongoing multicenter extension study. Molecular Genetics and Metabolism. 126(2). S133–S133. 6 indexed citations

Cleary, Maureen, Nicole Muschol, María L. Couce, et al.. (2019). ICV-administered tralesinidase alfa (BMN 250 NAGLU-IGF2) is well-tolerated and reduces heparan sulfate accumulation in the CNS of subjects with Sanfilippo syndrome type B (MPS IIIB). Molecular Genetics and Metabolism. 126(2). S40–S40. 6 indexed citations

Okur, İlyas, Maureen Cleary, Paul Harmatz, et al.. (2019). Natural history data for young subjects with Sanfilippo syndrome type B (MPS IIIB). Molecular Genetics and Metabolism. 126(2). S136–S136. 1 indexed citations

Cherukuri, Anu, Heather Cahan, Peter Slasor, et al.. (2018). Immunogenicity to cerliponase alfa intracerebroventricular enzyme replacement therapy for CLN2 disease: Results from a Phase 1/2 study. Clinical Immunology. 197. 68–76. 25 indexed citations

Muschol, Nicole, Maureen Cleary, María L. Couce, et al.. (2018). ICV-administered BMN 250 (NAGLU-IGF2) is well tolerated and reduces heparan sulfate accumulation in the CNS of subjects with Sanfilippo syndrome type B (MPS IIIB). Molecular Genetics and Metabolism. 123(2). S102–S102. 8 indexed citations

Okur, İlyas, Maureen Cleary, Paul Harmatz, et al.. (2018). Natural history data for young subjects with Sanfilippo syndrome type B (MPS IIIB). Molecular Genetics and Metabolism. 123(2). S108–S109. 1 indexed citations

10.

Schulz, Angela, Temitayo Ajayi, Nicola Specchio, et al.. (2018). Study of Intraventricular Cerliponase Alfa for CLN2 Disease. New England Journal of Medicine. 378(20). 1898–1907. 310 indexed citations breakdown →

11.

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2018). Long-term safety and efficacy of intracerebroventricular enzyme replacement therapy with cerliponase alfa in children with CLN2 disease: Two year results from an ongoing multicenter extension study. Molecular Genetics and Metabolism. 123(2). S126–S127. 1 indexed citations

12.

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2017). Intracerebroventricular cerliponase alfa for children with CLN2 disease: Interim results from an ongoing phase 2 extension study. European Journal of Paediatric Neurology. 21. e21–e21. 2 indexed citations

13.

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2017). Long-term safety and efficacy of intracerebroventricular enzyme replacement therapy with cerliponase alfa in children with CLN2 disease: interim results from an ongoing multicenter, multinational extension study. Molecular Genetics and Metabolism. 120(1-2). S120–S120. 2 indexed citations

14.

Reyes, Emily de los, Angela Schulz, Nicola Specchio, et al.. (2016). Intracerebroventricular Cerliponase Alfa (BMN 190) in Children with CLN2 disease: Results from a Phase 1/2, Open-Label, Dose-Escalation Study. 5 indexed citations

15.

Schulz, Angela, Nicola Specchio, Paul Gissen, et al.. (2016). Intracerebroventricular Cerliponase Alfa (BMN 190) in Children with CLN2 Disease: Interim Results from a Phase 1/2, Open-Label, Dose-Escalation Study. Neuropediatrics. 47(S 01). 4 indexed citations

16.

Cahan, Heather & Jaime G. Deville. (2011). Outcomes of Neonatal Candidiasis: The Impact of Delayed Initiation of Antifungal Therapy. International Journal of Pediatrics. 2011. 1–6. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact